硫酸镁、硝苯地平联合治疗妊娠期高血压疾病的临床疗效分析

Clinical Efficacy Analysis of Magnesium Sulfate and Nifedipine combined in the Treatment of Hypertensive Diseases during Pregnancy

目的探讨硫酸镁、硝苯地平联合治疗妊娠期高血压疾病的临床疗效分析。方法选择我医院从2017年1月至2018年12月收治的妊娠期高血压患者200例,分成两组,对照组患者采用硫酸镁治疗,观察组患者采用硫酸镁联合硝苯地平治疗,治疗周期为2个月,对于两组的临床应用效果进行对比分析。结果通过这次实验得出观察组硫酸镁联合硝苯地平治疗效果佳于对照组单用硫酸镁治疗效果,组间差异具有统计学意义(P<0.05)。结论对于妊娠期高血压患者采用硫酸镁联合硝苯地平治疗后,保证了胎儿的存活率,患者心理功能都得到了良好的改善,无任何不良反应且降压效果更为明显。

Objective To investigate the clinical efficacy of magnesium sulfate and nifedipine combined in the treatment of hypertensive disease during pregnancy. Methods 200 cases of hypertensive gestational patients from January 2017 to December 2018 were selected and divided into two groups. The control group was treated with magnesium sulfate, and the observation group was treated with magnesium sulfate and nifedipine. The treatment period was 2 months. The clinical effects of the two groups were compared and analyzed. Results The results showed that magnesium sulfate combined with nifedipine in the observation group was better than the control group with magnesium sulfate alone. The difference was statistically significant(P<0.05). Conclusion The fetal survival rate was guaranteed after the treatment of hypertensive patients with gestational magnesium sulfate combined with nifedipine, and the psychological function of the patients was improved. There was no adverse reaction and the hypotensive effect was more obvious.